Join Clinical Lab Manager and our panel of experts as we discuss how high-plex automated immunoassays facilitate critical discoveries in immune medicine, accelerating the development of advanced therapeutics across disciplines
University of California - San Francisco | Oct 05, 2020
Researchers gain new insight into why patients who initially respond well to immunotherapy drugs known as checkpoint inhibitors can develop resistance to these therapies
BioIVT now provides same-day or next-day global delivery of fresh blood and immune cell products from its seven blood donor centers located in the US and UK
Implications include clinical diagnostic test under development and targeted therapies
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.